1. Gardner MB, Luciw PA. Macaque models of human infectious disease. ILAR J. 2008;49(2):220-255. http://www.ncbi.nlm.nih.gov/pubmed/18323583.
2. Phillips KA, Bales KL, Capitanio JP, et al. Why Primate Models Matter. Am J
Primatol. 2014;76(9):801-827. doi:10.1002/ajp.22281.
3. Kumar S, Hedges SB. A molecular timescale for vertebrate evolution. Nature. 1998;392:917-920.
4. Lackner A a, Veazey RS. Current concepts in AIDS pathogenesis: insights from the SIV/macaque model. Annu Rev Med. 2007;58:461-476.
doi:10.1146/annurev.med.58.082405.094316.
5. Salazar-Gonzalez JF, Martinez-Maza O, Nishanian P, et al. Increased immune activation precedes the inflection point of CD4 T cells and the increased serum virus load in human immunodeficiency virus infection. J Infect Dis.
1998;178(2):423-430. http://www.ncbi.nlm.nih.gov/pubmed/9697722.
6. Agwu AL FL. Antiretroviral treatment, management challenges and outcomes in perinatally HIV-infected adolescents. J Int AIDS Soc. 2013;16:18579.
7. Hessell AJ, Jaworski JP, Epson E, et al. Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques. Nat Med. 2016;22(October 2015):1-9. doi:10.1038/nm.4063. 8. Barouch DH, Whitney JB, Moldt B, et al. Therapeutic efficacy of potent
neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys. Nature. 2013;503(7475):224-228. doi:10.1038/nature12744. 9. Gardner MR, Kattenhorn LM, Kondur HR, et al. AAV-expressed eCD4-Ig
provides durable protection from multiple SHIV challenges. Nature. 2015;519(7541):87-91. doi:10.1038/nature14264.
10. Martinez P, Sundling C, O’Dell S, Mascola JR, Wyatt RT, Karlsson Hedestam GB. Primate immune responses to HIV-1 Env formulated in the saponin-based adjuvant AbISCO-100 in the presence or absence of TLR9 co-stimulation. Sci Rep. 2015;5:8925. doi:10.1038/srep08925.
11. Dai K, He L, Khan SN, et al. Rhesus macaque B-cell responses to an HIV-1 trimer vaccine revealed by unbiased longitudinal repertoire analysis. MBio. 2015;6(6):1- 17. doi:10.1128/mBio.01375-15.
12. Francica JR, Sheng Z, Zhang Z, et al. Analysis of immunoglobulin transcripts and hypermutation following SHIVAD8 infection and protein-plus-adjuvant
90
immunization. Nat Commun. 2015;6:6565. doi:10.1038/ncomms7565. 13. Haynes BF, Saunders K, Kelsoe G, Mascola JR, Nabel GJ. The Cellular and
Molecular Biology of HIV-1 Broadly Neutralizing Antibodies. In: Molecular
Biology of B Cells.; 2015:441-461.
14. Frost SDW, Wrin T, Smith DM, et al. Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc Natl Acad Sci. 2005;102(51):18514-18519.
doi:10.1073/pnas.0504658102.
15. Burton DR, Poignard P, Stanfield RL, Wilson IA. Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science. 2012;337(6091):183-186. doi:10.1126/science.1225416.
16. Xu JL, Davis MM. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity. 2000;13(1):37-45.
http://www.ncbi.nlm.nih.gov/pubmed/10933393.
17. Watson CT, Steinberg KM, Huddleston J, et al. Complete haplotype sequence of the human immunoglobulin heavy-chain variable, diversity, and joining genes and characterization of allelic and copy-number variation. Am J Hum Genet.
2013;92(4):530-546. doi:10.1016/j.ajhg.2013.03.004.
18. Georgiou G, Ippolito GC, Beausang J, Busse CE, Wardemann H, Quake SR. The promise and challenge of high-throughput sequencing of the antibody repertoire.
Nat Biotechnol. 2014;32(2):158-168. doi:10.1038/nbt.2782.
19. Walker LM, Phogat SK, Chan-Hui P-Y, et al. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science. 2009;326(5950):285-289. doi:10.1126/science.1178746.
20. Zhu J, O’Dell S, Ofek G, et al. Somatic Populations of PGT135-137 HIV-1- Neutralizing Antibodies Identified by 454 Pyrosequencing and Bioinformatics.
Front Microbiol. 2012;3(September):315. doi:10.3389/fmicb.2012.00315.
21. Haynes BF, Kelsoe G, Harrison SC, Kepler TB. B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study. Nat Biotechnol.
2012;30(5):423-433. doi:10.1038/nbt.2197.
22. Jardine J, Julien J-P, Menis S, et al. Rational HIV immunogen design to target specific germline B cell receptors. Science. 2013;340(6133):711-716.
doi:10.1126/science.1234150.
23. Wu X, Zhang Z, Schramm CA, et al. Maturation and Diversity of the VRC01- Antibody Lineage over 15 Years of Chronic HIV-1 Infection. Cell. 2014:470-485.
91 doi:10.1016/j.cell.2015.03.004.
24. Zhu J, Wu X, Zhang B, et al. De novo identi fi cation of VRC01 class HIV-1 – neutralizing antibodies by next-generation sequencing of B-cell transcripts. 2013. doi:10.1073/pnas.1306262110/-
/DCSupplemental.www.pnas.org/cgi/doi/10.1073/pnas.1306262110.
25. Huang J, Kang BH, Pancera M, et al. Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface. Nature. 2014;515(7525):138- 142. doi:10.1038/nature13601.
26. Wu X, Yang Z-Y, Li Y, et al. Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1. Science (80- ).
2010;329(5993):856 LP-861.
http://science.sciencemag.org/content/329/5993/856.abstract.
27. Liao H-X, Lynch R, Zhou T, et al. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature. 2013;496(7446):469-476.
doi:10.1038/nature12053.
28. Bonsignori M, Zhou T, Sheng Z, et al. Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody. Cell. 2016;165(2):449-463. doi:10.1016/j.cell.2016.02.022.
29. Gibbs RA, Rogers J, Katze MG, et al. Evolutionary and biomedical insights from the rhesus macaque genome. Science. 2007;316(5822):222-234.
doi:10.1126/science.1139247.
30. Zhang X, Goodsell J, Norgren RB. Limitations of the rhesus macaque draft genome assembly and annotation. BMC Genomics. 2012;13(1):206.
doi:10.1186/1471-2164-13-206.
31. Sundling CC, Li YY, Huynh NN, et al. High-Resolution Definition of Vaccine- Elicited B Cell Responses Against the HIV Primary Receptor Binding Site. Sci
Transl Med. 2012;4(142):142ra96--142ra96. doi:10.1126/scitranslmed.3003752.
32. Bible JM, Howard W, Robbins H, Dunn-Walters DK. IGHV1, IGHV5 and IGHV7 subgroup genes in the rhesus macaque. Immunogenetics. 2003;54(12):867-873. doi:10.1007/s00251-003-0536-2.
33. Howard WA, Bible JM, Finlay-Dijsselbloem E, Openshaw S, Dunn-Walters DK. Immunoglobulin light-chain genes in the rhesus macaque II: lambda light-chain germline sequences for subgroups IGLV1, IGLV2, IGLV3, IGLV4 and IGLV5.
Immunogenetics. 2005;57(9):655-664. doi:10.1007/s00251-005-0020-2.
92
Immunoglobulin light-chain genes in the rhesus macaque I: kappa light-chain germline sequences for subgroups IGKV1, IGKV2 and IGKV3. Immunogenetics. 2005;57(3-4):210-218. doi:10.1007/s00251-005-0794-2.
35. Link JM, Hellinger M a, Schroeder HW. The Rhesus monkey immunoglobulin IGHD and IGHJ germline repertoire. Immunogenetics. 2002;54(4):240-250. doi:10.1007/s00251-002-0468-2.
36. Wiehe K, Easterhoff D, Luo K, et al. Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved. Immunity. 2014;41(6):909-918. doi:10.1016/j.immuni.2014.11.014. 37. Gao F, Bonsignori M, Liao H-X, et al. Cooperation of B cell lineages in induction
of HIV-1-broadly neutralizing antibodies. Cell. 2014;158(3):481-491. doi:10.1016/j.cell.2014.06.022.
38. Andrews S. FastQC A Quality Control tool for High Throughput Sequence Data. 2009.
39. Bolger AM, Lohse M, Usadel B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114-2120.
doi:10.1093/bioinformatics/btu170.
40. Luo R, Liu B, Xie Y, et al. SOAPdenovo2: an empirically improved memory- efficient short-read de novo assembler. Gigascience. 2012;1(1):18.
doi:10.1186/2047-217X-1-18.
41. Gurevich A, Saveliev V, Vyahhi N, Tesler G. QUAST: quality assessment tool for genome assemblies. Bioinformatics. 2013;29(8):1072-1075.
doi:10.1093/bioinformatics/btt086.
42. Boetzer M, Henkel C V., Jansen HJ, Butler D, Pirovano W. Scaffolding pre- assembled contigs using SSPACE. Bioinformatics. 2011;27(4):578-579. doi:10.1093/bioinformatics/btq683.
43. Boetzer M, Pirovano W. SSPACE-LongRead: scaffolding bacterial draft genomes using long read sequence information. BMC Bioinformatics. 2014;15(1):211. doi:10.1186/1471-2105-15-211.
44. Xue W, Li J-T, Zhu Y-P, et al. L_RNA_scaffolder: scaffolding genomes with transcripts. BMC Genomics. 2013;14(1):604. doi:10.1186/1471-2164-14-604. 45. Bankevich A, Nurk S, Antipov D, et al. SPAdes: a new genome assembly
algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19(5):455-477. doi:10.1089/cmb.2012.0021.
93
46. Wences AH, Schatz MC, Hernandez Wences A, Schatz MC. Metassembler: Merging and optimizing de novo genome assemblies. Genome Biol.
2015;16(1):207. doi:10.1186/s13059-015-0764-4.
47. Delcher AL, Kasif S, Fleischmann RD, Peterson J, White O, Salzberg SL. Alignment of whole genomes. Nucleic Acids Res. 1999;27(11):2369-2376. doi:10.1093/nar/27.11.2369.
48. Robinson J, Malik a, Parham P, Bodmer JG, Marsh SG. IMGT/HLA database--a sequence database for the human major histocompatibility complex. Tissue
Antigens. 2000;55(3):280-287. http://www.ncbi.nlm.nih.gov/pubmed/10777106.
49. Gurevich A, Saveliev V, Vyahhi N, Tesler G. QUAST: quality assessment tool for genome assemblies. Bioinformatics. 2013;29(8):1072-1075.
doi:10.1093/bioinformatics/btt086.
50. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013;30(12):2725-2729. doi:10.1093/molbev/mst197.
51. Noé L, Kucherov G. YASS: Enhancing the sensitivity of DNA similarity search.
Nucleic Acids Res. 2005;33(SUPPL. 2):540-543. doi:10.1093/nar/gki478.
52. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat
Methods. 2012;9(4):357-359. doi:10.1038/nmeth.1923.
53. Chen JM, Cooper DN, Chuzhanova N, Ferec C, Patrinos GP. Gene conversion: mechanisms, evolution and human disease. Nat Rev Genet. 2007;8(10):762-775. doi:10.1038/nrg2193.
54. Watson CT, Steinberg KM, Graves T a, et al. Sequencing of the human IG light chain loci from a hydatidiform mole BAC library reveals locus-specific signatures of genetic diversity. Genes Immun. 2014;16(July):1-11. doi:10.1038/gene.2014.56. 55. Sambrook JG, Bashirova A, Palmer S, et al. Single haplotype analysis
demonstrates rapid evolution of the killer immunoglobulin-like receptor (KIR) loci in primates. Genome Res. 2005;15(1):25-35. doi:10.1101/gr.2381205.
56. Pendleton M, Sebra R, Pang AWC, et al. Assembly and diploid architecture of an individual human genome via single-molecule technologies. Nat Methods.
2015;12(8):780-786. doi:10.1038/nmeth.3454.
57. Gnerre S, Maccallum I, Przybylski D, et al. High-quality draft assemblies of mammalian genomes from massively parallel sequence data. Proc Natl Acad Sci U
94
58. McCoy RC, Taylor RW, Blauwkamp TA, et al. Illumina TruSeq synthetic long- reads empower de novo assembly and resolve complex, highly-repetitive
transposable elements. PLoS One. 2014;9(9). doi:10.1371/journal.pone.0106689. 59. Yan G, Zhang G, Fang X, et al. Genome sequencing and comparison of two
nonhuman primate animal models, the cynomolgus and Chinese rhesus macaques.
Nat Biotechnol. 2011;29(11):1019-1023. doi:10.1038/nbt.1992.
60. Consortium 1000 Genomes. An integrated map of genetic variation from 1092 human genomes. Nature. 2012;491:56-65.
61. Yuan Q, Zhou Z, Lindell SG, et al. The rhesus macaque is three times as diverse but more closely equivalent in damaging coding variation as compared to the human. BMC Genet. 2012;13(1):52. doi:10.1186/1471-2156-13-52.
62. Trapnell C, Pachter L, Salzberg SL. TopHat: Discovering splice junctions with RNA-Seq. Bioinformatics. 2009;25(9):1105-1111.
doi:10.1093/bioinformatics/btp120.
63. Parra G, Bradnam K, Korf I. CEGMA: A pipeline to accurately annotate core genes in eukaryotic genomes. Bioinformatics. 2007;23(9):1061-1067.
doi:10.1093/bioinformatics/btm071.
64. Tarailo-Graovac M, Chen N. Using RepeatMasker to identify repetitive elements in genomic sequences. Curr Protoc Bioinformatics. 2009;Chapter 4(March):Unit 4.10. doi:10.1002/0471250953.bi0410s25.
65. Hoff KJ, Lange S, Lomsadze A, Borodovsky M, Stanke M. BRAKER1: Unsupervised RNA-Seq-based genome annotation with GeneMark-ET and AUGUSTUS. Bioinformatics. 2015;32(5):767-769.
doi:10.1093/bioinformatics/btv661.
66. Thomas PD, Kejariwal A, Campbell MJ, et al. PANTHER: A browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acids Res. 2003;31(1):334-341.
doi:10.1093/nar/gkg115.
67. Walter L, Ansari AA. MHC and KIR polymorphisms in rhesus macaque SIV infection. Front Immunol. 2015;6(OCT):1-7. doi:10.3389/fimmu.2015.00540. 68. Robinson J, Mistry K, Mcwilliam H, Lopez R, Marsh SGE. Ipd-the immuno
polymorphism database. Nucleic Acids Res. 2009;38(SUPPL.1):863-869. doi:10.1093/nar/gkp879.
69. Shukla SA, Rooney MS, Rajasagi M, et al. Comprehensive analysis of cancer- associated somatic mutations in class I HLA genes. Nat Biotechnol.
95
2015;33(11):1152-1158. doi:10.1038/nbt.3344.
70. Gough SCL, Simmonds MJ. The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action. Curr Genomics. 2007;8(7):453-465. doi:10.2174/138920207783591690.
71. Kean LS, Singh K, Blazar BR, Larsen CP. Nonhuman primate transplant models finally evolve: Detailed immunogenetic analysis creates new models and
strengthens the old. Am J Transplant. 2012;12(4):812-819. doi:10.1111/j.1600- 6143.2011.03873.x.
72. Kok T, Gaeguta A, Finnie J, Gorry PR, Churchill M, Li P. Designer antigens for elicitation of broadly neutralizing antibodies against HIV. Clin Transl Immunol. 2014;3(9):e24. doi:10.1038/cti.2014.22.
73. Apetrei C, Pandrea I, Mellors JW. Nonhuman primate models for HIV cure research. PLoS Pathog. 2012;8(8):e1002892. doi:10.1371/journal.ppat.1002892. 74. Ebeling M, Kung E, See A, et al. Genome-based analysis of the nonhuman primate
Macaca fascicularis as a model for drug safety assessment. Genome Res. 2011;21(10):1746-1756. doi:10.1101/gr.123117.111.
75. Pappas L, Foglierini M, Piccoli L, et al. Rapid development of broadly influenza neutralizing antibodies through redundant mutations. Nature. 2014;516(7531):418- 422. doi:10.1038/nature13764.
76. Martin MP, Gao X, Lee J-H, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet. 2002;31(4):429-434. doi:10.1038/ng934.
77. Martin MP, Qi Y, Gao X, et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet. 2007;39(6):733-740. doi:10.1038/ng2035. 78. Albrecht C, Malzahn D, Brameier M, Hermes M, Ansari AA, Walter L.
Progression to AIDS in SIV-infected rhesus macaques is associated with distinct KIR and MHC class I polymorphisms and NK cell dysfunction. Front Immunol. 2014;5(NOV):1-16. doi:10.3389/fimmu.2014.00600.
96 CURRICULUM VITAE
Akshaya Ramesh
Year of birth: 1988 [email protected] (678)-756-0614 Boston, MA EDUCATIONAugust 2012-December 2016 (expected)
Boston University, Boston, MA
M.A., Ph.D.: Genetics & Genomics August 2010-August 2012
Case Western Reserve University (CWRU), Cleveland, OH
M.S.: Biology May 2010
Sri Venkateswara College of Engineering, Chennai, India
B.Tech.: Biotechnology